Institutional investors purchased a net $13.4 million shares of GILD during the quarter ended March 2017 and now own 77.66% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Biotechnology industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
THE VANGUARD GROUP, INC. Bought 6.2 Million shares of Gilead Sciences
PARNASSUS INVESTMENTS Bought 4.6 Million shares of Gilead Sciences
CAPITAL RESEARCH & MANAGEMENT CO... Bought 3.1 Million shares of Gilead Sciences